Inorgen’s participative vision
Align research, patients, sponsors and professional community on the same goal.
ACADEMIC CENTERS, R&D INSTITUTIONS
Source lead candidates to enable drug development.
PATIENT ORGANIZATIONS and FOUNDATIONS
Identify specific needs and eventual assets that fit with an early stage development model.
SCIENTISTS and CLINICIANS
Decisions to continue or stop the course of action. Enable a risk mitigation development program.
DRUG DEVELOPMENT PROFESSIONALS
Accelerate the preparation of drug candidates partnering with experts in science, IP, regulatory, medical affairs, clinical research.
VENTURE CAPITAL / CORPORATE VENTURE
Highlight development and regulatory requirements to attract capital into a new initiative. Operate with a milestone-driven, capital efficient approach.
Add opportunities to increase the pipeline in selected therapeutic areas achieving operational flexibility between internal and external resources.
Conditions to enter into the acceleration process.
∙ First or Best in Class
∙ Patentability study
∙ PoC in animals
NICE TO HAVE
∙ Patient evaluation or application
Partnering with talents
Offering an exciting experience for people with initiative.
Inorgen is open to speak with talented and experienced individuals with an entrepreneurial approach who are willing to share benefits and risks of the Inorgen initiative.
Our goal is to create a cross-country competence group. We offer an exciting and cooperative working environment and propose clear rules of engagement for those willing to invest their efforts in the boot strapping phase of the company.
We are actively looking for people in the following areas :